1. WHO World malaria report. The “World malaria report 2019” at a glance. https://www.who.int/news-room/feature-stories/detail/world-malaria-report-2019 (accessed October 15, 2020).
2. Sun, J.; Konishi, Y.; Macina, T.; Kondo, N.; You, D. T. 4-Aminoquinazoline derivatives and pharmaceuticals containing the same. JP 2,657,760 (1997.06.06; Ono Pharmaceutical Co., Ltd.).
3. Campbell, S. F. Antihypertensive 4-amino-2-[4-(1,4-benzodioxan-2-carbonyl) piperazin-1-yl or homopiperazin-1-yl]quinazolines. U.S. 4,188,390 (1980.02.12; Pfizer Inc.).
4. Matier, W. L. and Catt, J. D. 2-Piperazinyl-6,7-dimethoxyquinazolines. U.S. 4,060,615 (1977. 11.29; Mead Johnson & Company).
5. Hess, H-J. E. Use of 2,4-diaminoquinazolines as hypotensive agents. U.S. 3,663,706 (1972. 05.16; Pfizer Inc.).